Cognitive behavioral therapy in patients with sickle cell disease

Area of Science:

• Medical Science
• Psychology

Background:

• Sickle Cell Disease (SCD) is a lifelong, inherited blood disorder affecting African Americans, with no known cure.
• SCD leads to anemia, reduced life expectancy, and severe pain episodes, necessitating frequent hospitalizations.
• Current treatments primarily rely on pharmacological interventions, with limited exploration of complementary psychological approaches.

Purpose of the Study:

• To investigate the efficacy of Cognitive Behavioral Therapy (CBT) as an adjunct to conventional treatments for Sickle Cell Disease (SCD).
• To assess the impact of CBT on pain control, quality of life, and role limitations in individuals with SCD.

Main Methods:

• A quasi-experimental, one-group pretest-posttest design was employed.
• Nine African American participants with SCD received three weekly educational sessions on CBT techniques.
• Intervention focused on methods such as attention diversion, coping self-statements, and behavioral activities.

Main Results:

• Participants showed a higher frequency of using CBT methods post-intervention.
• Improved pain control was observed due to increased utilization of learned CBT techniques.
• No significant improvements were noted in overall quality of life or the extent of role limitations.

Conclusions:

• Cognitive Behavioral Therapy (CBT) demonstrates potential benefits for managing pain in Sickle Cell Disease (SCD) when integrated with standard medical care.
• Barriers to the integration of psychological interventions like CBT into clinical practice for SCD patients persist.
• Further research with larger sample sizes and longer follow-up periods is warranted to fully establish the efficacy of CBT for chronic conditions like SCD.